# US 2009/0221591 A1 · Selective Inhibitors of Human Corticosteroid Synthases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0221591 A1
- Document ID: US20090221591A1
- Status: Published application
- Kind: A1
- Application number: 11/885,605
- Filed: 2006-03-02
- Published: 2009-09-03
- Earliest claimed: 2005-03-03
- Assignees: Universitat Des Saarlandes
- Inventors: Rolf W. Hartmann; Marieke Voets; Ursula Müller-Vieira
- Web page: https://patentgrep.com/patent/US20090221591A1

## CPC

- A61K 31/4164: 1,3-Diazoles
- A61K 31/4406: only substituted in position 3, e.g. zimeldine (nicotinic acid A61K31/455)
- A61K 31/4709: Non-condensed quinolines and containing further heterocyclic rings
- A61K 31/505: Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 5/40: Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
- C07D 213/16: containing only one pyridine ring
- C07D 213/30: Oxygen atoms
- C07D 213/55: Acids; Esters
- C07D 213/56: Amides
- C07D 213/57: Nitriles
- C07D 233/54: having two double bonds between ring members or between ring members and non-ring members
- C07D 233/56: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D 233/64: with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C07D 239/26: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 239/30: Halogen atoms or nitro radicals
- C07D 239/34: One oxygen atom
- C07D 263/32: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to compounds for selectively inhibiting human corticosteroid synthases CYP1 1 B1 and CYP1 1 B2, and to the production and use thereof for treating hypercortisolism, diabetes mellitus, hyperaldosteronism, cardiac insufficiency, myocardial fibrosis, depression, age-related cognitive decline and metabolic syndrome.

## Claims

### Claim at position 1

1-17. (canceled)

### Claim 18

A method of treating hyperaldosteronism, heart failure, myocardial fibrosis, hypercortisolism, diabetes mellitus, depression, age-related cognitive decline and metabolic syndrome comprising, administering to a patient in need of treatment a compound having a structure of formula (I)
wherein Y is selected from
T, U, V, W, and X are each independently selected from C and N;
R1 and R2 are independently selected from
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; provided that when U is nitrogen then R1 is absent; and when V is nitrogen then R2 is absent;
R1 can be taken together with R2 or with R1, or R2 can be taken together with R5 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R3 is a nitrogen-containing monocyclic or bicyclic heteroaryl residue that can be substituted with from 1 to 3 R12 residues;
R3 can be taken together with R6; or R3 can be taken together with either R7 or R8 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R4, R5, R6, R7, R8 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix)-NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; when T is nitrogen then R4 is absent; when W is nitrogen then R5 is absent;
when X is nitrogen then R6 is absent;
n is an integer of from 0 to 2;
when n=1, R7 or R9 can be taken together with R9 or R10 to form a double bond;
when n=2, either R7 or R8 can be taken together with either R9 or R10 to form a double bond; two R7 units on adjacent carbons, two R8 units on adjacent carbons, or a R7 unit and R8 unit units on adjacent carbons can be taken together to form a double bond;
R5 can be taken together with either R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R7 or R8 can be taken together with R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R10 is selected from
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
v) saturated or unsaturated C1-C3 cyclic alkylcarbonyl;
vi) arylalkyl;
vii) heteroarylalkyl;
viii) aryl;
ix) heteroaryl;
x) —COOR11
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
R11 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) aryl;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
each R12 is independently selected from:
i) H;
ii) hydroxy;
iii) halogen;
iv) —CN;
v) —COOH;
vi) —CHO;
vii) nitro;
viii) amino;
ix) mono- or bis(C1-C6 alkyl)amino;
x) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xi) saturated or unsaturated C3-C8 cyclic alkyl;
xii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
xiii) saturated or unsaturated C3-C8 cyclic alkoxy;
xiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
xv) saturated or unsaturated C3-C8 cyclic alkylcarbonyl;
xvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonyloxy;
xvii) saturated or unsaturated C3-C8 cyclic alkylcarbonyloxy;
xviii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonylamino;
xix) saturated or unsaturated C3-C8 cyclic alkylcarbonylamino;
xx) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-sulfonylamino;
xxi) saturated or unsaturated C3-C8 cyclic alkylsulfonylamino xxii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylthio;
xxiii) saturated or unsaturated C3-C8 cyclic alkylthio;
xxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsufinyl;
xxv) saturated or unsaturated C3-C8 cyclic alkylsufinyl;
xxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsulfonyl;
xxvii) saturated or unsaturated C3-C8 cyclic alkylsulfonyl;
xxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl;
xxix) saturated or unsaturated C3-C8 cyclic hydroxyalkyl;
xxx) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkoxy;
xxxi) saturated or unsaturated C3-C8 cyclic hydroxyalkoxy;
xxxii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyl;
xxxiii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyl;
xxxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyloxy;
xxxv) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyloxy;
xxxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylamino;
xxxvii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylamino;
xxxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkylcarbonylthio;
xxxix) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylthio;
xl) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylsulfonyl;
xli) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylsulfonyl;
xlii) mono- and bis(saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl)amino;
xliii) mono- and bis(saturated or unsaturated C3-C8 cyclic alkyl)amino;
xliv) mono- and polyhalogenated saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xlv) mono- and polyhalogenated saturated or unsaturated C3-C8 cyclic alkyl; or
a pharmaceutically acceptable salt thereof.

### Claim 19 (depends on 18)

The method according to claim 18, wherein Y is:
and
T, U, V, and W are each carbon atoms.

### Claim 20 (depends on 18)

The method according to claim 18, wherein Y is:
and
T, U, V, and W are each carbon atoms.

### Claim 21 (depends on 18)

The method according to claim 18, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 1 to 10 carbon atoms.

### Claim 22 (depends on 21)

The method according to claim 21, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 1 to 6 carbon atoms.

### Claim 23 (depends on 21)

The method according to claim 21, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 1 to 3 carbon atoms.

### Claim 24 (depends on 18)

The method according to claim 18, wherein the cyclic alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 3 to 8 carbon atoms.

### Claim 25 (depends on 18)

The method according to claim 18, wherein the aryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 3 to 18 carbon atoms.

### Claim 26 (depends on 18)

The method according to claim 18, wherein the aryl residues comprising R1, R2, R4, R6, R7, R8 and R9 are each independently anellated with one or more saturated rings.

### Claim 27 (depends on 18)

The method according to claim 18, wherein the rings that are anellated to the aryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are selected from cyclohexyl, cyclohexenyl, cyclopentyl, cyclopentenyl, benzyl, furanoyl, dihydropyranyl, pyranyl, pyrrolyl, imidazolyl, pyridyl and pyrimidyl.

### Claim 28 (depends on 18)

The method according to claim 18, wherein the aryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are each independently selected from anthracenyl, dihydronaphthyl, fluorenyl, hydrindanyl, indanyl, indanyl, naphthyl, phenanthrenyl, phenyl, and tetralinyl.

### Claim 29 (depends on 18)

The method according to claim 18, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 3 to 12 ring atoms.

### Claim 30 (depends on 18)

The method according to claim 18, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are each independently anellated with one or more saturated rings.

### Claim 31 (depends on 18)

The method according to claim 18, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 comprise from 1 to 5 heteroatoms selected from nitrogen, oxygen, and sulfur.

### Claim 32 (depends on 18)

The method according to claim 18, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are chosen from benzimidazolyl, benzothiazolyl, benzooxazolyo, quinazolyl, quinolyl, quinoxalinyl, cinnolilnyl, dihydroindolyl, dihyroisoindolyl, dihydropyranyl, dithiasolyl, homopiperidinyl, imidazolidinyl, imidazolinyl, imidazolyl, indazolyl, indolyl, isoquinolyl, isoindolyl, isothiazolidinyl, isothiazolyl, isoxazolidinyl, isoxazolyl, morpholinyl, oxadiazolyl, ooxazolidinyl, oxazolyl, phthalazinyl, piperazinyl, piperidyl, pteridinyl, purinyl, pyrazolidinyl, pyrazinyl, pyrazolyl, pyrazolinyl, pyridazinuyl, pyridyl, pyrimidyl, pyrrolidinyl, pyrrolidin-2onyl, prrolinyl, pyrrolyl, terazinyl, tetrazolyl, tetrahydropyrrolyl, thiadiazolyl, thiazinyl, thiazolidinyl, thiazolyl, thiazinyl and triazolyl.

### Claim 33 (depends on 18)

The method according to claim 18, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R10, R11 and R12 each independently have from 1 to 3 carbon atoms.

### Claim 34 (depends on 18)

The method according to claim 18, wherein n equals 0 or 1.

### Claim 35 (depends on 18)

The method according to claim 18, wherein R1 and R2 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2.

### Claim 36 (depends on 35)

The method according to claim 35, wherein R1 and R2 are each independently selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
iii) saturated or unsaturated C3-C8 cyclic alkoxy;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy; and
v) saturated or unsaturated C3-C8 cyclic arylalkoxy.

### Claim 37 (depends on 18)

The method according to claim 18, wherein R3 is monocyclic heteroaryl comprising from 5 to 10 ring atoms and from 1 to 3 nitrogen atoms.

### Claim 38 (depends on 18)

The method according to claim 18, wherein R3 is selected from isoquinolyl, imidazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridyl, pyrimidyl, pyrrolyl, thiazolyl, triazinyl and triazolyl.

### Claim 39 (depends on 18)

The method according to claim 18, wherein R4R5R6, R7R8 and R9 are independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxyl;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy; and
viii) saturated or unsaturated C3-C8 cyclic alkoxy.

### Claim 40 (depends on 18)

The method according to claim 18, wherein R10 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) heteroaryl.

### Claim 41 (depends on 18)

The method according to claim 18, wherein Y is either N or C;
T, U, V, and W are carbon atoms;
R1 is selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2;
R2 is selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2;
R3 is monocyclic heteroaryl comprising from 5 to 10 ring atoms and from 1 to 3 nitrogen atoms;
R4R5R6, R7R8 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxyl;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy; and
viii) saturated or unsaturated C3-C8 cyclic alkoxy
R10 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) heteroaryl; and
R12 is selected from:
i) H;
ii) halogen;
iii) hydroxy;
iv) CN;
v) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy.

### Claim 42 (depends on 18)

The method according to claim 18, wherein the compound has the formula:
wherein R1, R2, R5, R6, and R7 are each independently chosen from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
vi) heteroaryl;
vii) arylalkyloxy;
viii) —COOR11; or
ix) —CON(R11)2;
R11 is hydrogen or methyl.

### Claim 43 (depends on 42)

The method according to claim 42, wherein R1 is hydrogen or methoxy.

### Claim 44 (depends on 42)

The method according to claim 42, wherein R2 is chosen from:
i) H;
ii) hydroxy;
iii) methoxy;
iv) ethoxy;
v) n-propoxy;
vi) benzyloxy;
vii) cyano;
viii) bromo;
ix) pyridinyl;
x) —COOCH3;
xi) —CONH2; or
xii) —CONHCH3.

### Claim 45 (depends on 42)

The method according to claim 42, wherein R5 is hydrogen, chloro, bromo, or pyridinyl.

### Claim 46 (depends on 42)

The method according to claim 42, wherein R6 is hydrogen or chloro.

### Claim 47 (depends on 42)

The method according to claim 42, wherein R7 is hydrogen or methoxy.

### Claim 48 (depends on 42)

The method according to claim 42, wherein the compound is chosen from:
3-(naphthalen-2-yl)pyridine;
3-(6-methoxynaphthalen-2-yl)pyridine;
3-(6-hydroxynaphthalen-2-yl)pyridine;
3-(6-bromonaphthalen-2-yl)pyridine;
3-(6-ethoxynaphthalen-2-yl)pyridine;
3-(6-propoxynaphthalen-2-yl)pyridine;
3-(6-benzyloxynaphthalen-2-yl)pyridine;
3-(6-cyanonaphthalen-2-yl)pyridine;
3-(5-chloro-6-methoxynaphthalen-2-yl)pyridine;
3-(5-bromo-6-methoxynaphthalen-2-yl)pyridine;
3-[5-(pyridin-3-yl)-6-methoxynaphthalen-2-yl]pyridine;
3-(1,5-dichloro-6-methoxynaphthalen-2-yl)pyridine;
3-(7-methoxynaphthalen-2-yl)pyridine;
3-(1-chloro-7-methoxynaphthalen-2-yl)pyridine;
3-(3-methoxynaphthalen-2-yl)pyridine;
methyl 6-(pyridin-3-yl)-2-naphthoate;
6-(pyridin-3-yl)-2-naphthamide; and
N-methyl-6-(pyridin-3-yl)-2-naphthamide.

### Claim 49 (depends on 18)

The method according to claim 18, wherein the compound has the formula:
wherein R2 is chosen from:
i) H;
ii) hydroxy;
iii) methoxy;
iv) ethoxy;
v) n-propoxy;
vi) benzyloxy;
vii) cyano;
viii) bromo;
ix) pyridinyl;
xiii) —COOCH3;
xiv) —CONH2; or
xv) —CONHCH3.
R3 is heteroaryl;
R6 is hydrogen or methoxy; and
R7 is hydrogen or methoxy.

### Claim 50 (depends on 49)

The method according to claim 49, wherein R3 is chosen from 1-imidazolyl, 4(5)-imidazolyl, 5-(N-methyl)imidazolyl, 5-oxazolyl, 5-pyrimidyl, and 4-pyridyl.

### Claim 51 (depends on 49)

The method according to claim 49, wherein R2 is methoxy.

### Claim 52 (depends on 49)

The method according to claim 49, wherein R7 is methoxy.

### Claim 53 (depends on 49)

The method according to claim 49, wherein the compound is chosen from:
3-pyridin-3-ylquinoline;
2-pyridin-3-ylquinoline;
2-pyridin-3-ylquinoxaline;
3-(9-phenanthryl)pyridine;
1-(2-naphthyl)-1H-imidazole;
1-(3-methoxy-2-naphthyl)-1H-imidazole;
1-(6-methoxy-2-naphthyl)-1H-imidazole;
3-(1H-imidazol-1-yl)quinoline;
4-(naphthalene-2-yl)-1H-imidazole;
5-(naphthalene-2-yl)-1H-imidazole;
1-methyl-5-(2-naphthyl)-1H-imidazole;
5-(2-naphtyl)-1,3-oxazole;
5-(6-methoxy-2-naphthyl)pyrimidine; and
4-(6-methoxy-2-naphtyl)pyridine.

### Claim 54 (depends on 18)

The method according to claim 18, wherein the compound has the formula:
wherein R1 and R2 are each independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
R3 is heteroaryl;
R6 is hydrogen or saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
R7 is hydrogen or saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl; and
each R9 is independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl.

### Claim 55 (depends on 54)

The method according to claim 54, wherein R1 is hydrogen or methoxy.

### Claim 56 (depends on 54)

The method according to claim 54, wherein R2 is hydrogen or methoxy.

### Claim 57 (depends on 54)

The method according to claim 54, wherein R3 is chosen from isoquinolyl, imidazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridyl, pyrimidyl, pyrrolyl, thiazolyl, triazinyl and triazolyl.

### Claim 58 (depends on 57)

The method according to claim 57, wherein R3 is pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, and imidazol-5-yl.

### Claim 59 (depends on 54)

The method according to claim 54, wherein R6 is hydrogen, methyl, or ethyl.

### Claim 60 (depends on 54)

The method according to claim 54, wherein R7 is hydrogen, methyl, or ethyl.

### Claim 61 (depends on 54)

The method according to claim 54, wherein each R9 is independently hydrogen, methyl, or ethyl.

### Claim 62 (depends on 54)

The method according to claim 54, wherein the compound is chosen from:
3-(3,4-dihydronaphthalen-2-yl)pyridine;
3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine;
3-(7-methoxy-3,4-dihydronaphthalen-2-yl)pyridine;
3-(1-methyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(1-ethyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine;
4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine;
1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole; and
1-(6-methoxy-3,4-dihydronaphthalen-2-yl)-1H-imidazole.

### Claim 63 (depends on 18)

The method according to claim 18, wherein the compound has the formula:
wherein R1 and R2 are each independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
R3 is heteroaryl;
R6 is hydrogen or saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl; and
each R9 is independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl.

### Claim 64 (depends on 54)

The method according to claim 54, wherein R1 is hydrogen or methoxy.

### Claim 65 (depends on 54)

The method according to claim 54, wherein R2 is hydrogen or methoxy.

### Claim 66 (depends on 54)

The method according to claim 54, wherein R3 is chosen from isoquinolyl, imidazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridyl, pyrimidyl, pyrrolyl, thiazolyl, triazinyl and triazolyl.

### Claim 67 (depends on 57)

The method according to claim 57, wherein R3 is pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, and imidazol-5-yl.

### Claim 68 (depends on 54)

The method according to claim 54, wherein R6 is hydrogen, methyl, or ethyl.

### Claim 69 (depends on 54)

The method according to claim 54, wherein each R9 is independently hydrogen, methyl, or ethyl.

### Claim 70 (depends on 54)

The method according to claim 54, wherein the compound is chosen from:
1-(1H-inden-2-yl)-1H-imidazole;
3-(6-methoxy-1H-inden-2-yl)pyridine; and
3-(7-methoxy-1H-inden-2-yl)pyridine.

### Claim 71

A pharmaceutical composition comprising a compound having a structure of formula (I)
wherein Y is selected from
T, U, V, W, and X are each independently selected from C and N;
R1 and R2 are independently selected from
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii)-N(R11)2;
xxxviii)-NHCOR11; and
xxxix)-NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; provided that when U is nitrogen then R1 is absent; and when V is nitrogen then R2 is absent;
R1 can be taken together with R2 or with R1, or R2 can be taken together with R5 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R3 is a nitrogen-containing monocyclic or bicyclic heteroaryl residue that can be substituted with from 1 to 3 R12 residues;
R3 can be taken together with R6; or R3 can be taken together with either R7 or R8 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R4, R5, R6, R7, R8 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; when T is nitrogen then R4 is absent; when W is nitrogen then R5 is absent;
when X is nitrogen then R6 is absent;
n is an integer of from 0 to 2;
when n=1, R7 or R8 can be taken together with R9 or R10 to form a double bond;
when n=2, either R7 or R8 can be taken together with either R9 or R10 to form a double bond; two R7 units on adjacent carbons, two R8 units on adjacent carbons, or a R7 unit and R8 unit units on adjacent carbons can be taken together to form a double bond;
R5 can be taken together with either R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R7 or R8 can be taken together with R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R10 is selected from
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
v) saturated or unsaturated C1-C3 cyclic alkylcarbonyl;
vi) arylalkyl;
vii) heteroarylalkyl;
viii) aryl;
ix) heteroaryl;
x) —COOR11
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
R11 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) aryl;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
each R12 is independently selected from:
i) H;
ii) hydroxy;
iii) halogen;
iv) —CN;
v) —COOH;
vi) —CHO;
vii) nitro;
viii) amino;
ix) mono- or bis(C1-C6 alkyl)amino;
x) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xi) saturated or unsaturated C3-C8 cyclic alkyl;
xii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
xiii) saturated or unsaturated C3-C8 cyclic alkoxy;
xiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
xv) saturated or unsaturated C3-C8 cyclic alkylcarbonyl;
xvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonyloxy;
xvii) saturated or unsaturated C3-C8 cyclic alkylcarbonyloxy;
xviii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonylamino;
xix) saturated or unsaturated C3-C8 cyclic alkylcarbonylamino;
xx) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-sulfonylamino;
xxi) saturated or unsaturated C3-C8 cyclic alkylsulfonylamino xxii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylthio;
xxiii) saturated or unsaturated C3-C8 cyclic alkylthio;
xxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsufinyl;
xxv) saturated or unsaturated C3-C8 cyclic alkylsufinyl;
xxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsulfonyl;
xxvii) saturated or unsaturated C3-C8 cyclic alkylsulfonyl;
xxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl;
xxix) saturated or unsaturated C3-C8 cyclic hydroxyalkyl;
xxx) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkoxy;
xxxi) saturated or unsaturated C3-C8 cyclic hydroxyalkoxy;
xxxii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyl;
xxxiii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyl;
xxxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyloxy;
xxxv) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyloxy;
xxxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylamino;
xxxvii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylamino;
xxxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkylcarbonylthio;
xxxix) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylthio;
xl) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylsulfonyl;
xli) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylsulfonyl;
xlii) mono- and bis(saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl)amino;
xliii) mono- and bis(saturated or unsaturated C3-C8 cyclic alkyl)amino;
xliv) mono- and polyhalogenated saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xlv) mono- and polyhalogenated saturated or unsaturated C3-C8 cyclic alkyl; or
a pharmaceutically acceptable salt thereof;
provided the compound does not have the formula:
wherein R2 is halogen;
R6 is hydrogen, methyl, ethyl, n-propyl, or iso-propyl; and
R9 is hydrogen, methyl or ethyl; or
the compound does not have the formula:
wherein R3 is pyridyl; and
R9 is hydrogen or methyl; or
the compound does not have the formula:
wherein R6 is hydrogen or C1-C4 alkyl; and
R3 is 3-pyridyl or 4-pyridyl; or
the compound does not have the formula:

### Claim 72 (depends on 71)

A composition according to claim 71, wherein Y has the formula:
and
T, U, V, W, and X are carbon;
n is equal to 0 or 1;
R1 and R2 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2;
R3 is monocyclic heteroaryl comprising from 5 to 10 ring atoms and from 1 to 3 nitrogen atoms;
R4R5R6, R7R8 and R9 are independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxyl;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy; and
viii) saturated or unsaturated C3-C8 cyclic alkoxy; and
R10 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) heteroaryl.

### Claim 73 (depends on 72)

The composition according to claim 72, wherein R1 and R2 are each independently selected from:
i) H;
ii) fluorine;
iii) chlorine;
iv) bromine;
v) CN;
vi) hydroxy;
vii) —COOR11;
viii) —CON(R11)2;
ix) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
x) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy;
R3 is selected from oxazolyl, pyridyl, imidazolyl, and pyrimidyl;
R5 and R1 are each independently selected from H, fluorine, chlorine, or bromine;
R7 is selected from:
i) H;
ii) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy;
R4, R8, R9, and R10 are H;
R11 is H or C1-C3 alkyl.

### Claim 74 (depends on 73)

The composition according to claim 73, wherein R3 is selected from 3-pyridyl, 4-pyridyl, 1-imidazolyl, 4-imidazolyl, and 5-pyrimidyl.

### Claim 75 (depends on 74)

The composition according to claim 74, wherein R3 is 3-pyridyl.

### Claim 76 (depends on 71)

The composition according to claim 71, wherein the compound is selected from:
3-(naphthalen-2-yl)pyridine;
3-(6-methoxynaphthalen-2-yl)pyridine;
3-(6-hydroxynaphthalen-2-yl)pyridine;
3-(6-bromonaphthalen-2-yl)pyridine;
3-(6-ethoxynaphthalen-2-yl)pyridine;
3-(6-propoxynaphthalen-2-yl)pyridine;
3-(6-benzyloxynaphthalen-2-yl)pyridine;
3-(6-cyanonaphthalen-2-yl)pyridine;
3-(5-chloro-6-methoxynaphthalen-2-yl)pyridine;
3-(5-bromo-6-methoxynaphthalen-2-yl)pyridine;
3-[5-(pyridin-3-yl)-6-methoxynaphthalen-2-yl]pyridine;
3-(1,5-dichloro-6-methoxynaphthalen-2-yl)pyridine;
3-(7-methoxynaphthalen-2-yl)pyridine;
3-(1-chloro-7-methoxynaphthalen-2-yl)pyridine;
3-(3-methoxynaphthalen-2-yl)pyridine;
methyl 6-(pyridin-3-yl)-2-naphthoate;
6-(pyridin-3-yl)-2-naphthamide;
N-methyl-6-(pyridin-3-yl)-2-naphthamide; and
3-(1H-inden-2-yl)pyridine.

### Claim 77

A pharmaceutical composition for treating hyperaldosteronism, heart failure, myocardial fibrosis, hypercortisolism, diabetes mellitus, depression, age-related cognitive decline and metabolic syndrome, comprising one or more compounds having a structure of formula (I)
wherein Y is selected from
n=0 or 1;
R1 and R2 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2;
R3 is monocyclic heteroaryl comprising from 5 to 10 ring atoms and from 1 to 3 nitrogen atoms;
R4R5R6, R7R8 and R9 are independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxyl;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy; and
viii) saturated or unsaturated C3-C8 cyclic alkoxy; and
R10 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) heteroaryl;
provided the compound does not have the formula:
wherein R2 is halogen;
R6 is hydrogen, methyl, ethyl, n-propyl, or iso-propyl; and
R9 is hydrogen, methyl or ethyl; or
the compound does not have the formula:
wherein R3 is pyridyl; and
R9 is hydrogen or methyl; or
the compound does not have the formula:
wherein R6 is hydrogen or C1-C4 alkyl; and
R3 is 3-pyridyl or 4-pyridyl; or
the compound does not have the formula:

### Claim 78 (depends on 77)

A composition according to claim 77, wherein R1 and R2 are each independently selected from:
i) H;
ii) fluorine;
iii) chlorine;
iv) bromine;
v) CN;
vi) hydroxy;
vii) —COOR11;
viii) —CON(R11)2;
ix) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
x) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy;
R3 is selected from oxazolyl, pyridyl, imidazolyl, and pyrimidyl;
R5 and R6 are each independently selected from H, fluorine, chlorine, or bromine;
R7 is selected from:
i) H;
ii) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy;
R4, R8, R9, and R10 are H;
R11 is H or C1-C3 alkyl.

### Claim 79 (depends on 78)

The composition according to claim 78, wherein R3 is selected from 3-pyridyl, 4-pyridyl, 1-imidazolyl, 4-imidazolyl, and 5-pyrimidyl.

### Claim 80 (depends on 79)

The composition according to claim 79, wherein R3 is 3-pyridyl.

### Claim 81 (depends on 77)

The composition according to claim 77, wherein the compound is selected from:
3-(naphthalen-2-yl)pyridine;
3-(6-methoxynaphthalen-2-yl)pyridine;
3-(6-hydroxynaphthalen-2-yl)pyridine;
3-(6-bromonaphthalen-2-yl)pyridine;
3-(6-ethoxynaphthalen-2-yl)pyridine;
3-(6-propoxynaphthalen-2-yl)pyridine;
3-(6-benzyloxynaphthalen-2-yl)pyridine;
3-(6-cyanonaphthalen-2-yl)pyridine;
3-(5-chloro-6-methoxynaphthalen-2-yl)pyridine;
3-(5-bromo-6-methoxynaphthalen-2-yl)pyridine;
3-[5-(pyridin-3-yl)-6-methoxynaphthalen-2-yl]pyridine;
3-(1,5-dichloro-6-methoxynaphthalen-2-yl)pyridine;
3-(7-methoxynaphthalen-2-yl)pyridine;
3-(1-chloro-7-methoxynaphthalen-2-yl)pyridine;
3-(3-methoxynaphthalen-2-yl)pyridine;
methyl 6-(pyridin-3-yl)-2-naphthoate;
6-(pyridin-3-yl)-2-naphthamide;
N-methyl-6-(pyridin-3-yl)-2-naphthamide; and
3-(1H-inden-2-yl)pyridine.

### Claim 82

A compound having the formula (I)
wherein Y is selected from:
T, U, V, W, and X are each independently selected from C and N;
R1 and R2 are independently selected from
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; provided that when U is nitrogen then R1 is absent; and when V is nitrogen then R2 is absent;
R1 can be taken together with R2 or with R4, or R2 can be taken together with R5 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R3 is a nitrogen-containing monocyclic or bicyclic heteroaryl residue that can be substituted with from 1 to 3 R12 residues;
R3 can be taken together with R6; or R3 can be taken together with either R7 or R8 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R4, R5, R6, R7, R8 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; when T is nitrogen then R4 is absent; when W is nitrogen then R5 is absent;
when X is nitrogen then R6 is absent;
n is an integer of from 0 to 2;
when n=1, R7 or R8 can be taken together with R9 or R10 to form a double bond;
when n=2, either R7 or R8 can be taken together with either R9 or R10 to form a double bond; two R7 units on adjacent carbons, two R8 units on adjacent carbons, or a R7 unit and R9 unit units on adjacent carbons can be taken together to form a double bond;
R5 can be taken together with either R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R7 or R8 can be taken together with R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R10 is selected from
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
v) saturated or unsaturated C1-C3 cyclic alkylcarbonyl;
vi) arylalkyl;
vii) heteroarylalkyl;
viii) aryl;
ix) heteroaryl;
x) —COOR11
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
R11 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) aryl;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
each R12 is independently selected from:
i) H;
ii) hydroxy;
iii) halogen;
iv) —CN;
v) —COOH;
vi) —CHO;
vii) nitro;
viii) amino;
ix) mono- or bis(C1-C6 alkyl)amino;
x) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xi) saturated or unsaturated C3-C8 cyclic alkyl;
xii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
xiii) saturated or unsaturated C3-C8 cyclic alkoxy;
xiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
xv) saturated or unsaturated C3-C8 cyclic alkylcarbonyl;
xvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonyloxy;
xvii) saturated or unsaturated C3-C8 cyclic alkylcarbonyloxy;
xviii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonylamino;
xix) saturated or unsaturated C3-C8 cyclic alkylcarbonylamino;
xx) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-sulfonylamino;
xxi) saturated or unsaturated C3-C8 cyclic alkylsulfonylamino
xxii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylthio;
xxiii) saturated or unsaturated C3-C8 cyclic alkylthio;
xxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsufinyl;
xxv) saturated or unsaturated C3-C8 cyclic alkylsufinyl;
xxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsulfonyl;
xxvii) saturated or unsaturated C3-C8 cyclic alkylsulfonyl;
xxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl;
xxix) saturated or unsaturated C3-C8 cyclic hydroxyalkyl;
xxx) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkoxy;
xxxi) saturated or unsaturated C3-C8 cyclic hydroxyalkoxy;
xxxii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyl;
xxxiii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyl;
xxxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyloxy;
xxxv) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyloxy;
xxxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylamino;
xxxvii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylamino;
xxxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkylcarbonylthio;
xxxix) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylthio;
xl) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylsulfonyl;
xli) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylsulfonyl;
xlii) mono- and bis(saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl)amino;
xliii) mono- and bis(saturated or unsaturated C3-C8 cyclic alkyl)amino;
xliv) mono- and polyhalogenated saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xlv) mono- and polyhalogenated saturated or unsaturated C3-C8 cyclic alkyl; or
a pharmaceutically acceptable salt thereof;
provided the compound does not have the formula:
wherein R2 is halogen;
R6 is hydrogen, methyl, ethyl, n-propyl, or iso-propyl; and
R9 is hydrogen, methyl or ethyl; or
the compound does not have the formula:
wherein R3 is pyridyl; and
R9 is hydrogen or methyl; or
the compound does not have the formula:
wherein R6 is hydrogen or C1-C4 alkyl; and
R3 is 3-pyridyl or 4-pyridyl; or
the compound does not have the formula:

### Claim 83 (depends on 82)

A composition according to claim 82, wherein Y has the formula:
and
T, U, V, W, and X are carbon;
n is equal to 0 or 1;
R1 and R2 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2;
R3 is monocyclic heteroaryl comprising from 5 to 10 ring atoms and from 1 to 3 nitrogen atoms;
R4 R5 R6, R7R8 and R9 are independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxyl;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy; and
viii) saturated or unsaturated C3-C8 cyclic alkoxy; and
R10 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) heteroaryl.

### Claim 84 (depends on 82)

The composition according to claim 82, wherein R1 and R2 are each independently selected from:
i) H;
ii) fluorine;
iii) chlorine;
iv) bromine;
v) CN;
vi)hydroxy;
vii) —COOR11;
viii) —CON(R11)2;
ix) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
x) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy;
R3 is selected from oxazolyl, pyridyl, imidazolyl, and pyrimidyl;
R5 and R6 are each independently selected from H, fluorine, chlorine, or bromine;
R7 is selected from:
i) H;
ii) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy;
R4, R8, R9, and R10 are H;
R11 is H or C1-C3 alkyl.

### Claim 85 (depends on 82)

The composition according to claim 82, wherein R3 is selected from 3-pyridyl, 4-pyridyl, 1-imidazolyl, 4-imidazolyl, and 5-pyrimidyl.

### Claim 86 (depends on 85)

The composition according to claim 85, wherein R3 is 3-pyridyl.

### Claim 87 (depends on 82)

The composition according to claim 82, wherein the compound is selected from:
3-(naphthalen-2-yl)pyridine;
3-(6-methoxynaphthalen-2-yl)pyridine;
3-(6-hydroxynaphthalen-2-yl)pyridine;
3-(6-bromonaphthalen-2-yl)pyridine;
3-(6-ethoxynaphthalen-2-yl)pyridine;
3-(6-propoxynaphthalen-2-yl)pyridine;
3-(6-benzyloxynaphthalen-2-yl)pyridine;
3-(6-cyanonaphthalen-2-yl)pyridine;
3-(5-chloro-6-methoxynaphthalen-2-yl)pyridine;
3-(5-bromo-6-methoxynaphthalen-2-yl)pyridine;
3-[5-(pyridin-3-yl)-6-methoxynaphthalen-2-yl]pyridine;
3-(1,5-dichloro-6-methoxynaphthalen-2-yl)pyridine;
3-(7-methoxynaphthalen-2-yl)pyridine;
3-(1-chloro-7-methoxynaphthalen-2-yl)pyridine;
3-(3-methoxynaphthalen-2-yl)pyridine;
methyl 6-(pyridin-3-yl)-2-naphthoate;
6-(pyridin-3-yl)-2-naphthamide;
N-methyl-6-(pyridin-3-yl)-2-naphthamide; and
3-(1H-inden-2-yl)pyridine.

### Claim 88

A process for preparing a compound having the formula:
wherein Y is selected from
T, U, V, W, and X are each independently selected from C and N;
R1 and R2 are independently selected from
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; provided that when U is nitrogen then R1 is absent; and when V is nitrogen then R2 is absent;
R1 can be taken together with R2 or with R4, or R2 can be taken together with R5 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R3 is a nitrogen-containing monocyclic or bicyclic heteroaryl residue that can be substituted with from 1 to 3 R12 residues;
R3 can be taken together with R6; or R3 can be taken together with either R7 or R8 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R4, R5, R6, R7, R8 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; when T is nitrogen then R4 is absent; when W is nitrogen then R5 is absent;
when X is nitrogen then R6 is absent;
n is an integer of from 0 to 2;
when n=1, R7 or R8 can be taken together with R9 or R10 to form a double bond;
when n=2, either R7 or R8 can be taken together with either R9 or R10 to form a double bond; two R7 units on adjacent carbons, two R8 units on adjacent carbons, or a R7 unit and R8 unit units on adjacent carbons can be taken together to form a double bond;
R5 can be taken together with either R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R7 or R8 can be taken together with R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R10 is selected from
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
v) saturated or unsaturated C1-C3 cyclic alkylcarbonyl;
vi) arylalkyl;
vii) heteroarylalkyl;
viii) aryl;
ix) heteroaryl;
x) —COOR11
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
R11 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) aryl;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
each R12 is independently selected from:
i) H;
ii) hydroxy;
iii) halogen;
iv) —CN;
v) —COOH;
vi) —CHO;
vii) nitro;
viii) amino;
ix) mono- or bis(C1-C6 alkyl)amino;
x) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xi) saturated or unsaturated C3-C8 cyclic alkyl;
xii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
xiii) saturated or unsaturated C3-C8 cyclic alkoxy;
xiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
xv) saturated or unsaturated C3-C8 cyclic alkylcarbonyl;
xvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonyloxy;
xvii) saturated or unsaturated C3-C8 cyclic alkylcarbonyloxy;
xviii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonylamino;
xix) saturated or unsaturated C3-C8 cyclic alkylcarbonylamino;
xx) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-sulfonylamino;
xxi) saturated or unsaturated C3-C8 cyclic alkylsulfonylamino
xxii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylthio;
xxiii) saturated or unsaturated C3-C8 cyclic alkylthio;
xxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsufinyl;
xxv) saturated or unsaturated C3-C8 cyclic alkylsufinyl;
xxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsulfonyl;
xxvii) saturated or unsaturated C3-C8 cyclic alkylsulfonyl;
xxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl;
xxix) saturated or unsaturated C3-C8 cyclic hydroxyalkyl;
xxx) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkoxy;
xxxi) saturated or unsaturated C3-C8 cyclic hydroxyalkoxy;
xxxii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyl;
xxxiii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyl;
xxxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyloxy;
xxxv) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyloxy;
xxxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylamino;
xxxvii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylamino;
xxxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkylcarbonylthio;
xxxix) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylthio;
xl) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylsulfonyl;
xli) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylsulfonyl;
xlii) mono- and bis(saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl)amino;
xliii) mono- and bis(saturated or unsaturated C3-C8 cyclic alkyl)amino;
xliv) mono- and polyhalogenated saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xlv) mono- and polyhalogenated saturated or unsaturated C3-C8 cyclic alkyl, comprising:
a) providing a compound having the formula:
wherein (p)Hal is halogen or pseudohalide; and
b) reacting the compound of step (a) with a compound having the formula:
R3—B(OH)2

### Claim 89 (depends on 88)

The process according to claim 88, wherein (p)Hal is bromine or triflate.

### Claim 90 (depends on 88)

The process according to claim 88 wherein step (c) further comprises the catalyst Pd(PPh3)4.

### Claim 91

A process for preparing a compound having the formula:
wherein Y is selected from
T, U, V, and W are each independently selected from C and N;
R1 and R2 are independently selected from
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; provided that when U is nitrogen then R1 is absent; and when V is nitrogen then R2 is absent;
R1 can be taken together with R2 or with R4, or R2 can be taken together with R5 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R3 is a nitrogen-containing monocyclic or bicyclic heteroaryl residue that can be substituted with from 1 to 3 R12 residues;
R3 can be taken together with R6; or R3 can be taken together with either R7 or R8 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R4, R5, R6, R7, R1 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; when T is nitrogen then R4 is absent; when W is nitrogen then R5 is absent;
when X is nitrogen then R6 is absent;
n is an integer of from 0 to 2;
when n=1, R7 or R8 can be taken together with R9 or R10 to form a double bond;
when n=2, either R7 or R8 can be taken together with either R9 or R10 to form a double bond; two R7 units on adjacent carbons, two R8 units on adjacent carbons, or a R7 unit and R8 unit units on adjacent carbons can be taken together to form a double bond;
R5 can be taken together with either R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R7 or R8 can be taken together with R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R10 is selected from
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
v) saturated or unsaturated C1-C3 cyclic alkylcarbonyl;
vi) arylalkyl;
vii) heteroarylalkyl;
viii) aryl;
ix) heteroaryl;
x) —COOR11
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
R11 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) aryl;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
each R12 is independently selected from:
i) H;
ii) hydroxy;
iii) halogen;
iv) —CN;
v) —COOH;
vi) —CHO;
vii) nitro;
viii) amino;
ix) mono- or bis(C1-C6 alkyl)amino;
x) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xi) saturated or unsaturated C3-C8 cyclic alkyl;
xii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
xiii) saturated or unsaturated C3-C8 cyclic alkoxy;
xiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
xv) saturated or unsaturated C3-C8 cyclic alkylcarbonyl;
xvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonyloxy;
xvii) saturated or unsaturated C3-C8 cyclic alkylcarbonyloxy;
xviii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonylamino;
xix) saturated or unsaturated C3-C8 cyclic alkylcarbonylamino;
xx) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-sulfonylamino;
xxi) saturated or unsaturated C3-C8 cyclic alkylsulfonylamino
xxii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylthio;
xxiii) saturated or unsaturated C3-C8 cyclic alkylthio;
xxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsufinyl;
xxv) saturated or unsaturated C3-C8 cyclic alkylsufinyl;
xxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsulfonyl;
xxvii) saturated or unsaturated C3-C8 cyclic alkylsulfonyl;
xxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl;
xxix) saturated or unsaturated C3-C8 cyclic hydroxyalkyl;
xxx) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkoxy;
xxxi) saturated or unsaturated C3-C8 cyclic hydroxyalkoxy;
xxxii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyl;
xxxiii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyl;
xxxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyloxy;
xxxv) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyloxy;
xxxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylamino;
xxxvii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylamino;
xxxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkylcarbonylthio;
xxxix) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylthio;
xl) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylsulfonyl;
xli) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylsulfonyl;
xlii) mono- and bis(saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl)amino;
xliii) mono- and bis(saturated or unsaturated C3-C8 cyclic alkyl)amino;
xliv) mono- and polyhalogenated saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xlv) mono- and polyhalogenated saturated or unsaturated C3-C8 cyclic alkyl, comprising:
a) providing a compound having the formula:
b) brominating the compound from step (a) to form a compound having the formula:
wherein (p)Hal is halogen or pseudohalide; and
c) reacting the compound of step (b) with a compound having the formula:
R3—B(OH)2

### Claim 92 (depends on 91)

The process according to claim 91, wherein step (c) further comprises the catalyst Pd(PPh3)4.

### Claim 93

A method of selectively inhibiting mammalian P450 oxygenases, aldosterone synthase, or steroid 11β-hydroxylase comprising, administering to a human a compound having a structure of formula (I)
wherein Y is selected from
T, U, V, W, and X are each independently selected from C and N;
R1 and R2 are independently selected from
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
yl) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C1s cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix) —NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; provided that when U is nitrogen then R1 is absent; and when V is nitrogen then R2 is absent;
R1 can be taken together with R2 or with R4, or R2 can be taken together with R5 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R3 is a nitrogen-containing monocyclic or bicyclic heteroaryl residue that can be substituted with from 1 to 3 R12 residues;
R3 can be taken together with R6; or R3 can be taken together with either R7 or R8 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R4, R5, R6, R7, R8 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) nitro;
vi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
vii) saturated or unsaturated C3-C15 cyclic alkyl;
viii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
ix) saturated or unsaturated C3-C15 cyclic alkoxy;
x) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylcarbonyl;
xi) saturated or unsaturated C3-C15 cyclic alkylcarbonyl;
xii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonyloxy;
xiii) saturated or unsaturated C3-C15 cyclic alkylcarbonyloxy;
xiv) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-carbonylamino;
xv) saturated or unsaturated C3-C15 cyclic alkylcarbonylamino;
xvi) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl-sulfonylamino;
xvii) saturated or unsaturated C3-C15 cyclic alkylsulfonylamino
xviii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylthio;
xix) saturated or unsaturated C3-C15 cyclic alkylthio;
xx) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsufinyl;
xxi) saturated or unsaturated C3-C15 cyclic alkylsufinyl;
xxii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkylsulfonyl;
xxiii) saturated or unsaturated C3-C15 cyclic alkylsulfonyl;
xxiv) arylalkyl;
xxv) heteroarylalkyl;
xxvi) aryl;
xxvii) heteroaryl;
xxviii) arylalkyloxy;
xxix) heteroarylalkyloxy;
xxx) aryloxy;
xxxi) heteroaryloxy;
xxxii) —COOR11;
xxxiii) —CON(R11)2;
xxxiv) —SO3R11;
xxxv) —CHO;
xxxvi) —CHNR11;
xxxvii) —N(R11)2;
xxxviii) —NHCOR11; and
xxxix)-NHS(O)2R11;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units; when T is nitrogen then R4 is absent; when W is nitrogen then R5 is absent;
when X is nitrogen then R6 is absent;
n is an integer of from 0 to 2;
when n=1, R7 or R8 can be taken together with R9 or R10 to form a double bond;
when n=2, either R7 or R8 can be taken together with either R9 or R10 to form a double bond; two R7 units on adjacent carbons, two R8 units on adjacent carbons, or a R7 unit and R8 unit units on adjacent carbons can be taken together to form a double bond;
R5 can be taken together with either R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R7 or R8 can be taken together with R9 or R10 to form a saturated or unsaturated anellated aryl or heteroaryl ring, wherein the anellated aryl or heteroaryl ring can be substituted with from 1 to 3 R12 units;
R10 is selected from
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
v) saturated or unsaturated C1-C3 cyclic alkylcarbonyl;
vi) arylalkyl;
vii) heteroarylalkyl;
viii) aryl;
ix) heteroaryl;
x) —COOR11
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
R11 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) aryl;
wherein each alkyl, aryl or heteroaryl unit can be substituted with from 1 to 3 R12 units;
each R12 is independently selected from:
i) H;
ii) hydroxy;
iii) halogen;
iv) —CN;
v) —COOH;
vi) —CHO;
vii) nitro;
viii) amino;
ix) mono- or bis(C1-C6 alkyl)amino;
x) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xi) saturated or unsaturated C3-C8 cyclic alkyl;
xii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
xiii) saturated or unsaturated C3-C8 cyclic alkoxy;
xiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylcarbonyl;
xv) saturated or unsaturated C3-C8 cyclic alkylcarbonyl;
xvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonyloxy;
xvii) saturated or unsaturated C3-C8 cyclic alkylcarbonyloxy;
xviii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-carbonylamino;
xix) saturated or unsaturated C3-C8 cyclic alkylcarbonylamino;
xx) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl-sulfonylamino;
xxi) saturated or unsaturated C3-C8 cyclic alkylsulfonylamino xxii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylthio;
xxiii) saturated or unsaturated C3-C8 cyclic alkylthio;
xxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsufinyl;
xxv) saturated or unsaturated C3-C8 cyclic alkylsufinyl;
xxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain alkylsulfonyl;
xxvii) saturated or unsaturated C3-C8 cyclic alkylsulfonyl;
xxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl;
xxix) saturated or unsaturated C3-C8 cyclic hydroxyalkyl;
xxx) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkoxy;
xxxi) saturated or unsaturated C3-C8 cyclic hydroxyalkoxy;
xxxii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyl;
xxxiii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyl;
xxxiv) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonyloxy;
xxxv) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonyloxy;
xxxvi) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylamino;
xxxvii) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylamino;
xxxviii) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkylcarbonylthio;
xxxix) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylthio;
xl) saturated or unsaturated C1-C6 straight-chain or branched-chain hydroxyalkyl-carbonylsulfonyl;
xli) saturated or unsaturated C3-C8 cyclic hydroxyalkylcarbonylsulfonyl;
xlii) mono- and bis(saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl)amino;
xliii) mono- and bis(saturated or unsaturated C3-C8 cyclic alkyl)amino;
xliv) mono- and polyhalogenated saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
xlv) mono- and polyhalogenated saturated or unsaturated C3-C8 cyclic alkyl; or
a pharmaceutically acceptable salt thereof.

### Claim 94 (depends on 93)

The method according to claim 93, wherein Y is:
and
T, U, V, and W are each carbon atoms.

### Claim 95 (depends on 93)

The method according to claim 93, wherein Y is:
and
T, U, V, and W are each carbon atoms.

### Claim 96 (depends on 93)

The method according to claim 93, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 1 to 10 carbon atoms.

### Claim 97 (depends on 96)

The method according to claim 96, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 1 to 6 carbon atoms.

### Claim 98 (depends on 96)

The method according to claim 96, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 1 to 3 carbon atoms.

### Claim 99 (depends on 93)

The method according to claim 93, wherein the cyclic alkyl or alkoxy residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 3 to 8 carbon atoms.

### Claim 100 (depends on 93)

The method according to claim 93, wherein the aryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 3 to 18 carbon atoms.

### Claim 101 (depends on 93)

The method according to claim 93, wherein the aryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are each independently anellated with one or more saturated rings.

### Claim 102 (depends on 93)

The method according to claim 93, wherein the rings that are anellated to the aryl residues comprising R1, R2, RP4, R5, R6, R7, R8 and R9 are selected from cyclohexyl, cyclohexenyl, cyclopentyl, cyclopentenyl, benzyl, furanoyl, dihydropyranyl, pyranyl, pyrrolyl, imidazolyl, pyridyl and pyrimidyl.

### Claim 103 (depends on 93)

The method according to claim 93, wherein the aryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are each independently selected from anthracenyl, dihydronaphthyl, fluorenyl, hydrindanyl, indanyl, indanyl, naphthyl, phenanthrenyl, phenyl, and tetralinyl.

### Claim 104 (depends on 93)

The method according to claim 93, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 each independently have from 3 to 12 ring atoms.

### Claim 105 (depends on 93)

The method according to claim 93, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are each independently anellated with one or more saturated rings.

### Claim 106 (depends on 93)

The method according to claim 93, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 comprise from 1 to 5 heteroatoms selected from nitrogen, oxygen, and sulfur.

### Claim 107 (depends on 93)

The method according to claim 93, wherein the heteroaryl residues comprising R1, R2, R4, R5, R6, R7, R8 and R9 are chosen from benzimidazolyl, benzothiazolyl, benzooxazolyo, quinazolyl, quinolyl, quinoxalinyl, cinnolilnyl, dihydroindolyl, dihyroisoindolyl, dihydropyranyl, dithiasolyl, homopiperidinyl, imidazolidinyl, imidazolinyl, imidazolyl, indazolyl, indolyl, isoquinolyl, isoindolyl, isothiazolidinyl, isothiazolyl, isoxazolidinyl, isoxazolyl, morpholinyl, oxadiazolyl, ooxazolidinyl, oxazolyl, phthalazinyl, piperazinyl, piperidyl, pteridinyl, purinyl, pyrazolidinyl, pyrazinyl, pyrazolyl, pyrazolinyl, pyridazinuyl, pyridyl, pyrimidyl, pyrrolidinyl, pyrrolidin-2onyl, prrolinyl, pyrrolyl, terazinyl, tetrazolyl, tetrahydropyrrolyl, thiadiazolyl, thiazinyl, thiazolidinyl, thiazolyl, thiazinyl and triazolyl.

### Claim 108 (depends on 93)

The method according to claim 93, wherein the straight-chain or branched-chain alkyl or alkoxy residues comprising R10, R11 and R12 each independently have from 1 to 3 carbon atoms.

### Claim 109 (depends on 93)

The method according to claim 93, wherein n equals 0 or 1.

### Claim 110 (depends on 93)

The method according to claim 93, wherein R1 and R2 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2.

### Claim 111 (depends on 93)

The method according to claim 93, wherein R1 and R2 are each independently selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
iii) saturated or unsaturated C3-C8 cyclic alkoxy;
iv) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy; and
v) saturated or unsaturated C3-C8 cyclic arylalkoxy.

### Claim 112 (depends on 93)

The method according to claim 93, wherein R3 is monocyclic heteroaryl comprising from 5 to 10 ring atoms and from 1 to 3 nitrogen atoms.

### Claim 113 (depends on 93)

The method according to claim 93, wherein R3 is selected from isoquinolyl, imidazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridyl, pyrimidyl, pyrrolyl, thiazolyl, triazinyl and triazolyl.

### Claim 114 (depends on 93)

The method according to claim 93, wherein R4R5R6, R7R8 and R9 are independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxyl;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy; and
viii) saturated or unsaturated C3-C8 cyclic alkoxy.

### Claim 115 (depends on 93)

The method according to claim 93, wherein R10 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) heteroaryl.

### Claim 116 (depends on 93)

The method according to claim 93, wherein Y is either N or C;
T, U, V, and W are carbon atoms;
R1 is selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2;
R2 is selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy;
viii) saturated or unsaturated C3-C8 cyclic alkoxy;
ix) saturated or unsaturated C1-C6 straight-chain or branched-chain arylalkoxy;
x) saturated or unsaturated C3-C8 cyclic arylalkoxy;
xi) —COOR11; and
xii) —CON(R11)2;
R3 is monocyclic heteroaryl comprising from 5 to 10 ring atoms and from 1 to 3 nitrogen atoms;
R4R5R6, R7R8 and R9 are each independently selected from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxyl;
v) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C3-C8 cyclic alkyl;
vii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkoxy; and
viii) saturated or unsaturated C3-C8 cyclic alkoxy
R10 is selected from:
i) H;
ii) saturated or unsaturated C1-C6 straight-chain or branched-chain alkyl;
iii) saturated or unsaturated C3-C8 cyclic alkyl; and
iv) heteroaryl; and
R12 is selected from:
i) H;
ii) halogen;
iii) hydroxy;
iv) CN;
v) saturated or unsaturated C1-C3 straight-chain or branched-chain alkyl;
vi) saturated or unsaturated C1-C3 straight-chain or branched-chain alkoxy.

### Claim 117 (depends on 93)

The method according to claim 93, wherein the compound has the formula:
wherein R1, R2, R5, R6, and R7 are each independently chosen from:
i) H;
ii) halogen;
iii) CN;
iv) hydroxy;
v) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
vi) heteroaryl;
vii) arylalkyloxy;
viii) —COOR11; or
ix) —CON(R11)2;
R11 is hydrogen or methyl.

### Claim 118 (depends on 117)

The method according to claim 117, wherein R1 is hydrogen or methoxy.

### Claim 119 (depends on 117)

The method according to claim 117, wherein R2 is chosen from:
i) H;
ii) hydroxy;
iii) methoxy;
iv) ethoxy;
v) n-propoxy;
vi) benzyloxy;
vii) cyano;
viii) bromo;
ix) pyridinyl;
x) —COOCH3;
xi) —CONH2; or
xii) —CONHCH3.

### Claim 120 (depends on 117)

The method according to claim 117, wherein R5 is hydrogen, chloro, bromo, or pyridinyl.

### Claim 121 (depends on 117)

The method according to claim 117, wherein R6 is hydrogen or chloro.

### Claim 122 (depends on 117)

The method according to claim 117, wherein R7 is hydrogen or methoxy.

### Claim 123 (depends on 117)

The method according to claim 117, wherein the compound is chosen from:
3-(naphthalen-2-yl)pyridine;
3-(6-methoxynaphthalen-2-yl)pyridine;
3-(6-hydroxynaphthalen-2-yl)pyridine;
3-(6-bromonaphthalen-2-yl)pyridine;
3-(6-ethoxynaphthalen-2-yl)pyridine;
3-(6-propoxynaphthalen-2-yl)pyridine;
3-(6-benzyloxynaphthalen-2-yl)pyridine;
3-(6-cyanonaphthalen-2-yl)pyridine;
3-(5-chloro-6-methoxynaphthalen-2-yl)pyridine;
3-(5-bromo-6-methoxynaphthalen-2-yl)pyridine;
3-[5-(pyridin-3-yl)-6-methoxynaphthalen-2-yl]pyridine;
3-(1,5-dichloro-6-methoxynaphthalen-2-yl)pyridine;
3-(7-methoxynaphthalen-2-yl)pyridine;
3-(1-chloro-7-methoxynaphthalen-2-yl)pyridine;
3-(3-methoxynaphthalen-2-yl)pyridine;
methyl 6-(pyridin-3-yl)-2-naphthoate;
6-(pyridin-3-yl)-2-naphthamide; and
N-methyl-6-(pyridin-3-yl)-2-naphthamide.

### Claim 124 (depends on 93)

The method according to claim 93, wherein the compound has the formula:
wherein R2 is chosen from:
i) H;
ii) hydroxy;
iii) methoxy;
iv) ethoxy;
v) n-propoxy;
vi) benzyloxy;
vii) cyano;
viii) bromo;
ix) pyridinyl;
x) —COOCH3;
xi) —CONH2; or
xii) —CONHCH3.
R3 is heteroaryl;
R6 is hydrogen or methoxy; and
R7 is hydrogen or methoxy.

### Claim 125 (depends on 124)

The method according to claim 124, wherein R3 is chosen from 1-imidazolyl, 4(5)-imidazolyl, 5-(N-methyl)imidazolyl, 5-oxazolyl, 5-pyrimidyl, and 4-pyridyl.

### Claim 126 (depends on 124)

The method according to claim 124, wherein R2 is methoxy.

### Claim 127 (depends on 124)

The method according to claim 124, wherein R7 is methoxy.

### Claim 128 (depends on 124)

The method according to claim 124, wherein the compound is chosen from:
3-pyridin-3-ylquinoline;
2-pyridin-3-ylquinoline;
2-pyridin-3-ylquinoxaline;
3-(9-phenanthryl)pyridine;
1-(2-naphthyl)-1H-imidazole;
1-(3-methoxy-2-naphthyl)-1H-imidazole;
1-(6-methoxy-2-naphthyl)-1H-imidazole;
3-(1H-imidazol-1-yl)quinoline;
4-(naphthalene-2-yl)-1H-imidazole;
5-(naphthalene-2-yl)-1H-imidazole;
1-methyl-5-(2-naphthyl)-1H-imidazole;
5-(2-naphtyl)-1,3-oxazole;
5-(6-methoxy-2-naphthyl)pyrimidine; and
4-(6-methoxy-2-naphtyl)pyridine.

### Claim 129 (depends on 93)

The method according to claim 93, wherein the compound has the formula:
wherein R1 and R2 are each independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
R3 is heteroaryl;
R6 is hydrogen or saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl;
R7 is hydrogen or saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl; and
each R9 is independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl.

### Claim 130 (depends on 129)

The method according to claim 129, wherein R1 is hydrogen or methoxy.

### Claim 131 (depends on 129)

The method according to claim 129, wherein R2 is hydrogen or methoxy.

### Claim 132 (depends on 129)

The method according to claim 129, wherein R3 is chosen from isoquinolyl, imidazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridyl, pyrimidyl, pyrrolyl, thiazolyl, triazinyl and triazolyl.

### Claim 133 (depends on 132)

The method according to claim 132, wherein R3 is pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, and imidazol-5-yl.

### Claim 134 (depends on 129)

The method according to claim 129, wherein R6 is hydrogen, methyl, or ethyl.

### Claim 135 (depends on 129)

The method according to claim 129, wherein R7 is hydrogen, methyl, or ethyl.

### Claim 136 (depends on 129)

The method according to claim 129, wherein each R9 is independently hydrogen, methyl, or ethyl.

### Claim 137 (depends on 129)

The method according to claim 129, wherein the compound is chosen from:
3-(3,4-dihydronaphthalen-2-yl)pyridine;
3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine;
3-(7-methoxy-3,4-dihydronaphthalen-2-yl)pyridine;
3-(1-methyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(1-ethyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine;
3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine;
4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine;
1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole; and
1-(6-methoxy-3,4-dihydronaphthalen-2-yl)-1H-imidazole.

### Claim 138 (depends on 93)

The method according to claim 93, wherein the compound has the formula:
wherein R1 and R2 are each independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkoxy;
R3 is heteroaryl;
R6 is hydrogen or saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl; and
each R9 is independently chosen from:
i) H; or
ii) saturated or unsaturated C1-C10 straight-chain or branched-chain alkyl.

### Claim 139 (depends on 138)

The method according to claim 138, wherein R1 is hydrogen or methoxy.

### Claim 140 (depends on 138)

The method according to claim 138, wherein R2 is hydrogen or methoxy.

### Claim 141 (depends on 138)

The method according to claim 138, wherein R3 is chosen from isoquinolyl, imidazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridyl, pyrimidyl, pyrrolyl, thiazolyl, triazinyl and triazolyl.

### Claim 142 (depends on 141)

The method according to claim 141, wherein R3 is pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, and imidazol-5-yl.

### Claim 143 (depends on 138)

The method according to claim 138, wherein R6 is hydrogen, methyl, or ethyl.

### Claim 144 (depends on 138)

The method according to claim 138, wherein each R9 is independently hydrogen, methyl, or ethyl.

### Claim 145 (depends on 138)

The method according to claim 138, wherein the compound is chosen from:
1-(1H-inden-2-yl)-1H-imidazole;
3-(6-methoxy-1H-inden-2-yl)pyridine; and
3-(7-methoxy-1H-inden-2-yl)pyridine.

### Claim 146 (depends on 77)

The composition according to claim 77, further comprising an additional pharmacologically active compound.
